Navigation Links
Medivation Announces Participation in 27th Annual J.P. Morgan Healthcare Conference
Date:1/8/2009

SAN FRANCISCO, Jan. 8 /PRNewswire-FirstCall/ -- Medivation, Inc. (Nasdaq: MDVN) today announced that David Hung, M.D., president and chief executive officer, will present at the 27th Annual J.P. Morgan Healthcare Conference on Wednesday, January 14, at 10:00 a.m. Pacific Time at the Westin St. Francis Hotel in San Francisco.

Dr. Hung will provide an overview of Medivation and its clinical development programs for Dimebon for Alzheimer's and Huntington's diseases and MDV3100 for prostate cancer.

A live audio webcast will be available on the "Events and Presentations" page of the "Investor Relations" section of the Company's website at http://www.medivation.com. A replay also will be available for 30 days following the live presentation.

About Medivation

Medivation, Inc. is a biopharmaceutical company focused on the rapid development of novel small molecule drugs to treat serious diseases for which there are limited treatment options. Medivation aims to transform the treatment of these diseases and offer hope to critically ill patients and their caregivers. In September 2008, Medivation entered into a global agreement with Pfizer Inc to develop and commercialize Dimebon for the treatment of Alzheimer's and Huntington's diseases. With Pfizer, the Company is conducting a broad Dimebon clinical development program, including a pivotal and confirmatory Phase 3 trial, known as the CONNECTION study, in patients with mild-to-moderate Alzheimer's disease. The program also includes additional trials planned to begin this year in Alzheimer's disease, as well as further development of Dimebon in patients with mild-to-moderate Huntington's disease. In addition, a Phase 1-2 clinical trial of MDV3100 in patients with castration-resistant (also
'/>"/>

SOURCE Medivation, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Medivation to Announce Early Positive Data from Phase 1-2 Hormone Refractory Prostate Cancer Trial and Host Conference Call and Webcast on Monday, November 5, 2007
2. Medivation Plans to Initiate Pivotal Confirmatory Phase 3 Trial of Dimebon(TM) for Alzheimers Disease in Second Quarter of 2008
3. Medivation to Present at Cowen and Companys 28th Annual Health Care Conference
4. Medivation Announces Participation in Upcoming Conferences
5. HHS Announces $75 Million in Supplemental Funding to States for Pandemic Flu Preparedness
6. CRC Health Group Announces Acquisition of Bayside Marin Recovery Center, San Rafael
7. UHW Announces: Antelope Valley Hospital Caregivers and Board Vote to Ratify First Union Contract With SEIU UHW-West
8. HEI, Inc. Announces Sale of RFID Division Assets
9. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Zyloprim(R)
10. Mettler-Toledo International Inc. Announces Webcast of Presentation at Thomas Weisel Partners 2007 Healthcare Conference
11. Z Trim Announces Revocation of Gregory Halpern Severence Agreement
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/18/2015)... "I recognized the need for a ... said an inventor from Cincinnati, Ohio. "This need inspired ... developed the Slyde Door to offer an alternative to ... It provides convenient storage space for an evacuation stretcher. ... for patients. , This offers added peace of ...
(Date:4/18/2015)... April 18, 2015 Lower-auto-insurance.com has released ... accurate auto insurance quotes . , Drivers ... by comparing quotes. A professional insurance brokerage website can ... quotes, in a simple, convenient way. The whole process ... anyone. , Comparing online car insurance quotes is ...
(Date:4/18/2015)... York, NY (PRWEB) April 18, 2015 On ... Internal Security Threat Report , which they say, “exposes a ... how many new malware variants were introduced in 2014 - ... took for Zero Day threats to be identified and patched ... it is abundantly clear that doing business in a digital ...
(Date:4/17/2015)... (PRWEB) April 18, 2015 Heritage Woods ... begin its Supportive Living Week Celebration on April 20 ... having a healthy mind, body and soul. , The ... McLeansboro, Illinois, serves older adults of all incomes, including ... their independence. , Supportive Living Week is observed every ...
(Date:4/17/2015)... Alcohol and Violence , The National Council ... and driving has been the focus of much public ... link between alcohol and crime received less public attention. ... sexual assault, and their relationship to alcohol have been ... adults in America were drinking alcohol at the time ...
Breaking Medicine News(10 mins):Health News:Auto Insurance Quotes Can Provide Accurate Results! 2Health News:Cyber Attackers Continue to Fine Tune Deception and Stealth Tactics According to New Report 2Health News:Cyber Attackers Continue to Fine Tune Deception and Stealth Tactics According to New Report 3Health News:Cyber Attackers Continue to Fine Tune Deception and Stealth Tactics According to New Report 4Health News:Cyber Attackers Continue to Fine Tune Deception and Stealth Tactics According to New Report 5Health News:Heritage Woods of McLeansboro Affordable Assisted Living to Celebrate Supportive Living Week 2Health News:Heritage Woods of McLeansboro Affordable Assisted Living to Celebrate Supportive Living Week 3Health News:Narconon Arrowhead Raises Awareness on Alcohol Related Prevention 2Health News:Narconon Arrowhead Raises Awareness on Alcohol Related Prevention 3
... than Canada, study finds , THURSDAY, Feb. 25 (HealthDay ... among women, explain why arthritis is more common in ... new study. , Researchers at the Toronto Western Research ... that the prevalence of arthritis in the United States ...
... ... healthcare performance management strategies are the way to more effectively control healthcare costs across ... ... the Healthcare Performance Management (HPM) Institute, WellNet today expressed its support for -- and ...
... ... a leading medical informatics company, has launched a new enterprise platform for its revolutionary ... 5 systems., , ... Milwaukee, WI (PRWEB) February 25, 2010 -- TeraMedica Healthcare Technology , a leading ...
... ... RTLS Technology Platform strengthen further the technology’s position as the ultraSound choice for ... ... world leader in ultrasound-based real time locating systems for hospitals and long-term care ...
... ... ... , ... , , ...
... Advanced cancer patients who regularly received massages averaging 14 ... in stress scores over four weeks, according to results of ... American Psychosocial Oncology Society. In the study, sponsored by ... of a DVD program to provide massage to patients at ...
Cached Medicine News:Health News:WellNet Supports HPM Institute Director in Calling for More Active Enterprise Involvement in Managing Healthcare Quality and Costs 2Health News:TeraMedica Launches Evercore – Clinical Enterprise Suite 5.0 Now on Linux 2Health News:Sonitor Technologies Announces New Staff Tag and Battery Powered Ultrasound Receiver 2Health News:Catholic Charities USA Calls for Affordable and Accessible Healthcare for All 2Health News:Catholic Charities USA Calls for Affordable and Accessible Healthcare for All 3Health News:Family members reduce stress in advanced cancer patients with 14 minute massages 2
(Date:4/17/2015)...  AbbVie Inc. ("AbbVie") (NYSE / CHX / Euronext Paris ... expiration of its exchange offer to acquire all of the ... p.m., New York City time, on ... AbbVie also voluntarily withdrew its initial Notification and Report Form ... the FTC with additional time to review the proposed transaction.  ...
(Date:4/17/2015)... April 17, 2015 CVS Health Corporation (NYSE: ... on Friday, May 1, 2015, at 8:30 a.m. (EDT) ... financial results. An audio webcast of the ... Relations portion of the CVS Health website for all ... . This webcast will be archived and available on ...
(Date:4/17/2015)... , April 17, 2015  In Detroit, where three ... mortality rate is two and one half times of the ... 6 of 10 infants that die in Detroit ... sobering statistics that Covenant Community Care, a faith-based, charitable non-profit ... poised to change thanks to a charitable donation by Konica ...
Breaking Medicine Technology:AbbVie Extends Exchange Offer to Acquire Pharmacyclics, Inc. 2AbbVie Extends Exchange Offer to Acquire Pharmacyclics, Inc. 3AbbVie Extends Exchange Offer to Acquire Pharmacyclics, Inc. 4Covenant Community Care to Receive Donated SONIMAGE P3 Handheld Ultrasound from Konica Minolta Medical Imaging 2Covenant Community Care to Receive Donated SONIMAGE P3 Handheld Ultrasound from Konica Minolta Medical Imaging 3Covenant Community Care to Receive Donated SONIMAGE P3 Handheld Ultrasound from Konica Minolta Medical Imaging 4
... daily dosages of milnacipran 100,mg and 200 mg ... pain and other core symptoms associated,with fibromyalgia syndrome ... at the 2007 American College of Rheumatology meeting ... responders in a six-month,study were sustained for up ...
... Repligen Corporation,(Nasdaq: RGEN ) today announced positive results ... formulation of uridine, in patients with bipolar,disorder. This was ... or a placebo twice a day for six-weeks. Patients ... their symptoms at baseline,with the exception of mania for ...
Cached Medicine Technology:Milnacipran Demonstrated Significant Improvement in Pain and the Core Symptoms of Fibromyalgia Syndrome, Data Show 2Milnacipran Demonstrated Significant Improvement in Pain and the Core Symptoms of Fibromyalgia Syndrome, Data Show 3Milnacipran Demonstrated Significant Improvement in Pain and the Core Symptoms of Fibromyalgia Syndrome, Data Show 4Milnacipran Demonstrated Significant Improvement in Pain and the Core Symptoms of Fibromyalgia Syndrome, Data Show 5Milnacipran Demonstrated Significant Improvement in Pain and the Core Symptoms of Fibromyalgia Syndrome, Data Show 6Milnacipran Demonstrated Significant Improvement in Pain and the Core Symptoms of Fibromyalgia Syndrome, Data Show 7Milnacipran Demonstrated Significant Improvement in Pain and the Core Symptoms of Fibromyalgia Syndrome, Data Show 8Repligen Reports Positive Phase 2a Clinical Trial Results of RG2417 for Symptoms of Bipolar Disorder 2Repligen Reports Positive Phase 2a Clinical Trial Results of RG2417 for Symptoms of Bipolar Disorder 3Repligen Reports Positive Phase 2a Clinical Trial Results of RG2417 for Symptoms of Bipolar Disorder 4
... Olympus is proud to announce the next ... a good thing even better.,Now you have ... The CYF-4 and CYF-4A feature improved optics, ... smoother insertion of instruments. In addition, the ...
... Thermotherapy™ is an advanced transurethral microwave ... of benign prostate hyperplasia (BPH). TherMatrx ... BPH thermotherapy treatment in the United ... TherMatrx does not require cutting, heavy ...
... release of the OES Pro line of One-Piece ... commonly used cystoscopy sheaths has taken Olympus Rigid ... have one instrument that performs it all. Thanks ... offer a superior channel size while maintaining the ...
Fast, accurate SpO2 measurements always within reach....
Medicine Products: